Shyh-Ming Yang

National Institutes of Health

*This is an algorithmically generated author record based on publicly available information.

See Latest Publications

See Most Cited Publications

SciProfiles

ORCID Profile

Google Scholar

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

National Institutes of Health

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years

Research Subjects

Research Interests

Shyh-Ming Yang has a total of 130 co-authors. Here are the top co-authors by number of shared publications:

Ganesha Rai
National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA
31 shared publications
Adam Yasgar
National Center for Advancing Translational Sciences
30 shared publications
Alexey V. Zakharov
National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA
30 shared publications
Natalia J. Martinez
National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA
30 shared publications
Alexis L. Scott
Department of Bioengineering Swanson School of Engineering University of Pittsburgh Pittsburgh PA 15219 USA
29 shared publications
Anton Simeonov
National Institutes of Health
29 shared publications

Latest Publications

Sort by

Open Access
Website
Google Scholar
- 2 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
by Pengfei Yu, Shuwen Cao, Shyh-Ming Yang, Ganesha Rai, Natalia J. Martinez, Adam Yasgar, Alexey V. Zakharov, Anton Simeonov, William A. Molina Arocho, Graham P. Lobel, et al.
Supplementary Figure S4 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
Website
Google Scholar
- 2 February 2024
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S4 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
by Pengfei Yu, Shuwen Cao, Shyh-Ming Yang, Ganesha Rai, Natalia J. Martinez, Adam Yasgar, Alexey V. Zakharov, Anton Simeonov, William A. Molina Arocho, Graham P. Lobel, et al.
Supplementary Figure S4 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
Open Access
Website
Google Scholar
- 2 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
by Pengfei Yu, Shuwen Cao, Shyh-Ming Yang, Ganesha Rai, Natalia J. Martinez, Adam Yasgar, Alexey V. Zakharov, Anton Simeonov, William A. Molina Arocho, Graham P. Lobel, et al.
Supplementary Figure S6 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
Website
Google Scholar
- 2 February 2024
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S6 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
by Pengfei Yu, Shuwen Cao, Shyh-Ming Yang, Ganesha Rai, Natalia J. Martinez, Adam Yasgar, Alexey V. Zakharov, Anton Simeonov, William A. Molina Arocho, Graham P. Lobel, et al.
Supplementary Figure S6 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
Open Access
Website
Google Scholar
- 2 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Data Legends from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
by Pengfei Yu, Shuwen Cao, Shyh-Ming Yang, Ganesha Rai, Natalia J. Martinez, Adam Yasgar, Alexey V. Zakharov, Anton Simeonov, William A. Molina Arocho, Graham P. Lobel, et al.
Legends for supplementary figures and tables.
Website
Google Scholar
- 2 February 2024
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Data Legends from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
by Pengfei Yu, Shuwen Cao, Shyh-Ming Yang, Ganesha Rai, Natalia J. Martinez, Adam Yasgar, Alexey V. Zakharov, Anton Simeonov, William A. Molina Arocho, Graham P. Lobel, et al.
Legends for supplementary figures and tables.
Open Access
Website
Google Scholar
- 2 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
by Pengfei Yu, Shuwen Cao, Shyh-Ming Yang, Ganesha Rai, Natalia J. Martinez, Adam Yasgar, Alexey V. Zakharov, Anton Simeonov, William A. Molina Arocho, Graham P. Lobel, et al.
Safetyscreen assay for C86 performed at eurofins.
Website
Google Scholar
- 2 February 2024
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table 3 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
by Pengfei Yu, Shuwen Cao, Shyh-Ming Yang, Ganesha Rai, Natalia J. Martinez, Adam Yasgar, Alexey V. Zakharov, Anton Simeonov, William A. Molina Arocho, Graham P. Lobel, et al.
Safetyscreen assay for C86 performed at eurofins.
Open Access
Website
Google Scholar
- 2 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S7 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
by Pengfei Yu, Shuwen Cao, Shyh-Ming Yang, Ganesha Rai, Natalia J. Martinez, Adam Yasgar, Alexey V. Zakharov, Anton Simeonov, William A. Molina Arocho, Graham P. Lobel, et al.
Supplementary Figure S7 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
Website
Google Scholar
- 2 February 2024
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S7 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
by Pengfei Yu, Shuwen Cao, Shyh-Ming Yang, Ganesha Rai, Natalia J. Martinez, Adam Yasgar, Alexey V. Zakharov, Anton Simeonov, William A. Molina Arocho, Graham P. Lobel, et al.
Supplementary Figure S7 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
Open Access
Website
Google Scholar
- 2 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
by Pengfei Yu, Shuwen Cao, Shyh-Ming Yang, Ganesha Rai, Natalia J. Martinez, Adam Yasgar, Alexey V. Zakharov, Anton Simeonov, William A. Molina Arocho, Graham P. Lobel, et al.
Supplementary Figure S2 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
Website
Google Scholar
- 2 February 2024
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S2 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
by Pengfei Yu, Shuwen Cao, Shyh-Ming Yang, Ganesha Rai, Natalia J. Martinez, Adam Yasgar, Alexey V. Zakharov, Anton Simeonov, William A. Molina Arocho, Graham P. Lobel, et al.
Supplementary Figure S2 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
Open Access
Website
Google Scholar
- 2 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
by Pengfei Yu, Shuwen Cao, Shyh-Ming Yang, Ganesha Rai, Natalia J. Martinez, Adam Yasgar, Alexey V. Zakharov, Anton Simeonov, William A. Molina Arocho, Graham P. Lobel, et al.
Table comparing various key pharmacokinetic parameters (Assay, left column) between C-91 and C-86.
Website
Google Scholar
- 2 February 2024
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table 2 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
by Pengfei Yu, Shuwen Cao, Shyh-Ming Yang, Ganesha Rai, Natalia J. Martinez, Adam Yasgar, Alexey V. Zakharov, Anton Simeonov, William A. Molina Arocho, Graham P. Lobel, et al.
Table comparing various key pharmacokinetic parameters (Assay, left column) between C-91 and C-86.
Open Access
Website
Google Scholar
- 2 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
by Pengfei Yu, Shuwen Cao, Shyh-Ming Yang, Ganesha Rai, Natalia J. Martinez, Adam Yasgar, Alexey V. Zakharov, Anton Simeonov, William A. Molina Arocho, Graham P. Lobel, et al.
Website
Google Scholar
- 2 February 2024
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table 1 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
by Pengfei Yu, Shuwen Cao, Shyh-Ming Yang, Ganesha Rai, Natalia J. Martinez, Adam Yasgar, Alexey V. Zakharov, Anton Simeonov, William A. Molina Arocho, Graham P. Lobel, et al.
Open Access
Website
Google Scholar
- 2 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
by Pengfei Yu, Shuwen Cao, Shyh-Ming Yang, Ganesha Rai, Natalia J. Martinez, Adam Yasgar, Alexey V. Zakharov, Anton Simeonov, William A. Molina Arocho, Graham P. Lobel, et al.
Supplementary Figure S6 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
Website
Google Scholar
- 2 February 2024
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S6 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
by Pengfei Yu, Shuwen Cao, Shyh-Ming Yang, Ganesha Rai, Natalia J. Martinez, Adam Yasgar, Alexey V. Zakharov, Anton Simeonov, William A. Molina Arocho, Graham P. Lobel, et al.
Supplementary Figure S6 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
Open Access
Website
Google Scholar
- 2 February 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
by Pengfei Yu, Shuwen Cao, Shyh-Ming Yang, Ganesha Rai, Natalia J. Martinez, Adam Yasgar, Alexey V. Zakharov, Anton Simeonov, William A. Molina Arocho, Graham P. Lobel, et al.
Supplementary Figure S1 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
Website
Google Scholar
- 2 February 2024
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S1 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
by Pengfei Yu, Shuwen Cao, Shyh-Ming Yang, Ganesha Rai, Natalia J. Martinez, Adam Yasgar, Alexey V. Zakharov, Anton Simeonov, William A. Molina Arocho, Graham P. Lobel, et al.
Supplementary Figure S1 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma

Show all